Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

26.25
-0.1200-0.46%
Volume:233.76K
Turnover:6.24M
Market Cap:1.55B
PE:-20.45
High:28.13
Open:26.45
Low:25.89
Close:26.37
Loading ...

Stock Track | Janux Therapeutics Soars 6.52% Pre-Market Following Analyst's Buy Rating

Stock Track
·
1 hour ago

Promising Pipeline and Strategic Advancements Justify Buy Rating for Janux Therapeutics Inc

TIPRANKS
·
2 hours ago

Buy Rating Affirmed for Janux Therapeutics: Promising Clinical Data and Superior Efficacy of Lead Program JANX007

TIPRANKS
·
15 hours ago

Janux Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
18 hours ago

BRIEF-Janux Therapeutics Q1 Basic EPS USD -0.38

Reuters
·
19 hours ago

Janux Therapeutics Q1 Operating Income USD -34.897 Million

THOMSON REUTERS
·
19 hours ago

Janux Therapeutics: $1.01 Billion in Cash, Cash Equivalents, and Short-Term Investments at End of Q1

THOMSON REUTERS
·
19 hours ago

Buy Rating for Janux Therapeutics Inc. Driven by Strategic Advancements in Prostate Cancer Treatment with JANX007

TIPRANKS
·
07 May

Buy Rating for Janux Therapeutics Inc: Promising PFS Data and Attractive Valuation

TIPRANKS
·
06 May

Buy Rating for Janux Therapeutics Inc: Promising Clinical Trial Results and Positive Outlook for JANX007

TIPRANKS
·
06 May

Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential

Insider Monkey
·
05 May

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Illumina (ILMN)

TIPRANKS
·
05 May

Janux Therapeutics Initiates Phase 1B Expansion Studies With Janx007 in Patients With Prostate Cancer and Provides Program Updates

THOMSON REUTERS
·
05 May

Janux Therapeutics Inc - Updates on Janx007 and Janx008 Expected in H2 2025

THOMSON REUTERS
·
05 May

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates

Business Wire
·
05 May

Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Insider Monkey
·
05 May

Janux Therapeutics Inc. CBO Andrew Hollman Reports Disposal of Common Shares

Reuters
·
03 May

Small to Mid-Cap Biotechnology Firms Likely to Continue to Face Macro Headwinds, BofA Securities Says

MT Newswires Live
·
03 Apr

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?

Insider Monkey
·
28 Mar

Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode?

Insider Monkey
·
27 Mar